MASH Cities

??With Thanksgiving around the corner, let's start a chain of gratitude to thank those making a difference in metabolic and liver health! At MASH Cities, we believe healthier communities are built by the dedication of health leaders, patient advocates, patients, officials and neighbors who care deeply about creating change. This season, let’s recognize and celebrate them. ?? "I want to thank [NAME] for [their impact or support], because..." ?? Tag someone you're grateful for and share why below. We'd love to hear who has inspired you and uplift those working to tackle the MASLD/MASH public health threat. #Thanksgiving #ChainOfGratitude #Gratitude #MASHCities #CommunityHealth #MASLD

?? Join MASH Cities Chair Jeffrey V. Lazarus on November 16, 2024, at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting in San Diego, where he and others will be tackling liver cancer’s toughest challenges. #Livercancer remains one of the most lethal cancers worldwide. While #MASLD is a leading cause of advanced chronic liver disease, including primary liver cancer, we’re still not doing enough to raise awareness—especially among vulnerable populations who also face food insecurity, obesity, and other critical health risks. Take a look at:? ?? Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria (https://lnkd.in/dRg65zgE) ?? Food inequity and insecurity and MASLD: burden, challenges, and interventions (https://lnkd.in/e2Sx5K5z) The expert panel, “Leave No One Behind – Forgotten Aspects in Liver Cancer” will hear from the likes of ?? ??? Prof. Masatoshi Kudo ???Prof. Zobair Younossi ??? Homie Razavi ??? Dee Lee ??? Su Wang ??? Tingting Z. ... and others! Together, they’ll address not only the critical issues that impact liver cancer outcomes, but also why prevention efforts must urgently reach those at highest risk. ??The Hilton San Diego Gaslamp Quarter, Room: Gaslamp, from 1–2 PM, and let’s work to ensure that no one is left behind. #LiverCancerAwareness #AASLD #MASLD #PreventionisKey #FoodInsecurity

?? This World Diabetes Day's theme focuses on diabetes care and well-being. But, what does this mean when we talk about MASLD, especially in younger generations who are living longer lives? We often speak about MASLD/MASH with types 2 diabetes in adults, but today we're shifting the focus to highlight that the risk of #liverdisease exists for any age. Here's a supporting article to read further about the matter: ?? Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type 1 diabetes (https://lnkd.in/da9Ejqzd) #Diabeteslife #Prevention #IntegratedCare #Noncommunicablediseases #metabolichealth International Diabetes Federation Christopher Kopka Jeffrey V. Lazarus Dana Ivancovsky Wajcman Meena Bansal American Diabetes Association American Diabetes Association: Northern California American Diabetes Association Nashville Scott Isaacs, MD, FACP, FACE Arnaldo J Acosta Garaban Rosa Maria Ramirez Vela MD, EMBA Prof. Shira Zelber Sagi Lori Wenz, MSN, AGNP-C, BC-ADM, FOMA Nuha Ali El Sayed, MD, MMSc Jonathan G. Stine, MD MSc, FACP Christine Maalouf M Shafi Kuchay Abdullah Bhana Fatty Liver Alliance Elizabeth Ball Lepkowski, MATD Michele St. Pierre, BSN, RN charles SAAB

?? World Diabetes Day is coming up this Thursday, Nov 14th, highlighting the importance of diabetes care and overall well-being. To get ready for the day, we thought we'd give you a chance to test your knowledge ?? about the association between type 2 diabetes mellitus (#T2DM) and MASLD/MASH. Unfortunately, the synergistic effect of MASLD & T2DM increase morbidity and mortality risks for those living with the two conditions. Vote in our poll below and let’s raise awareness together on the link between these metabolic health challenges—and why an integrated approach to care matters ever more. -- To discover the answer, we recommend taking a look at: ?? En Li Cho?E,?Ang?CZ,?Quek?J, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut?2023;72:2138-2148. (https://lnkd.in/dgBjtbZt) #WorldDiabetesDay #T2D #MASLD #MASH #IntegratedCare #Endocrinology

??? November marks one year of the #HealthyNYC campaign—but there’s still work to be done. Metabolic health issues like MASLD and MASH remain under-addressed and under-recognized, even as they continue rising as a #publichealth threat. Swipe through to learn why NYC Department of Health and Mental Hygiene’s has a unique chance to improve metabolic health and make strides toward a healthier, longer future for all New Yorkers?? -- For info & resources about MASLD/MASH, we recommend some key basics?? 1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature (American Association for the Study of Liver Diseases (AASLD) - https://lnkd.in/e438jcV7 2. Economist Impact US policy landscape brief on MASLD/MASH-https://lnkd.in/egPBWmKt 3. A global action agenda for turning the tide on steatotic liver disease (formerly known as fatty liver disease) - https://lnkd.in/dC9FgwGh 4. A global research priority agenda to advance public health responses to fatty liver disease (Journal of Hepatology ) - https://lnkd.in/ef6tAcNQ #MetabolicHealth #MASLD #NYCHealth #HealthAwareness Jeffrey V. Lazarus Meena Bansal Christopher Kopka Empire Liver Foundation (ELF) Ayman El-Mohandes, MBBCh, MD,MPH,FAAP NYC Health + Hospitals Fund for Public Health in NYC Joxel Garcia, MD, MBA Ashwin Vasan American Liver Foundation Bloomberg Philanthropies Sejal Hathi, MD, MBA Megan Ranney Darren Walker Simbo Ige MD, MS, MPH Ashish Jha New York City Council James McDonald MD MPH Gustavo Rivera Amy Paulin Anne Williams Isom george gresham Jose Pagan Michael Dowling New York State IDDD Nurses Association Angela Profeta Margaret Pastuszko Manny Pastreich Mercedes Narcisse Lynn Schulman Bea Grause Danielle Holahan Eric Linzer Amir Bassiri Philip Ozuah Junior Harewood

?? Exploring disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria The 2023 nomenclature has defined criteria for #SteatoticLiverDisease (SLD), including #MASLD, alcohol-associated liver disease (#ALD), and the overlapping MASLD/ALS (#MetALD). Here's one of the latest studies to delve into potential racial and ethnic disparities in SLD prevalence among US adults based on the new nomenclature. ?? Why It Matters: Addressing these disparities is essential for developing effective public health interventions and ensuring equitable healthcare for all communities. Discover the full analysis and join the conversation on advancing #healthequity and #publichealth. Click below to read more! ?? https://lnkd.in/dRg65zgE #LiverHealth #DiversityInHealthcare #HealthDisparities

Episode 6, Season 3 is out... (but not on Netflix) To watch the latest on EASL | The Home of Hepatology policy dialogues, you'll want to tune in below ?? https://lnkd.in/eTCU7Ex5 In this episode???, MASH Cities Chair Jeffrey V. Lazarus and President of the American Association for the Study of Liver Diseases (AASLD) W Ray Kim discuss the critical need for liver disease representation at the upcoming Fourth High-level Meeting of the United Nations General Assembly on the prevention and control of NCDs in 2025. They also cover topics like the World Health Organization newly adopted "best buys" and how it targets risk factors for liver disease ?? You won't want to miss out!

According to the?NYC Mayor’s Office of Food Policy annual 2022 Food Metrics Annual Report, an estimated 1.2 million (14.6%) New York City residents were food insecure. (source:https://lnkd.in/dGdvksuu) What does that mean for cities like NYC and their residents when we know that food insecurity and socioeconomic status play a major role in liver disease prevalence, severity, outcomes and hepatic risk factors (e.g. unhealthy diets ??)? Metabolic dysfunction-associated steatotic liver disease (#MASLD) is now the most common liver disease globally ??. #FoodInsecurity is an "upstream" risk factor for MASLD, advanced fibrosis and greater all-cause mortality among those living with liver disease. If we do not intervene on food insecurity at four major levels (environment, policy, community and health care), we cannot ↘? reduce the burden of liver disease, and consequently, close the gap on social and health inequities. ?? Read the latest on the current research in the field, the need for implementing proven interventions, and the role #liverspecialists especially can have: https://lnkd.in/e2Sx5K5z

You ask, and you shall receive! ?? We're proud to share the recording of the first-ever policy event on #MASLD and #MASH, which took place alongside the United Nations General Assembly week on September 23rd. Supported by Barcelona Institute for Global Health (ISGlobal) and programmed by Economist Impact, the event welcomed an exclusive fireside chat with ?? ???? David Kershenobich, Secretary of Health of Mexico ???? H.E. Hanan Mohamed Al Kuwari, Minister of public health, Ministry of Public Health - Qatar. The video recording also shows the dynamic and insightful discussion with 4 expert panellists, including: ?? Jeffrey V. Lazarus, Professor of Global Health, CUNY Graduate School of Public Health and Health Policy ?? Johanna Ralston, CEO, World Obesity Federation ?? Arun Sanyal, Director, VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine ?? Christoph Benn, Director for Global Health Diplomacy, Joep Lange Institute Free free to watch, share and repost as we continue raising awareness of MASLD and MASH at a city, national and global level to place MASLD and MASH as priority agenda items at the upcoming?World Health Assembly?in early 2025 and?the 4th High-level Meeting of the United Nations General Assembly on the Prevention and Control of NCDs. ?? https://lnkd.in/dBh-25FR --- Cindy Serdjebi Fatty Liver Alliance Tess E. B. Echosens Jasmina Cunmulaj Leonor Mendoza Bellgardt Brian Li Han Wong Mário Pessoa Joxel Garcia, MD, MBA NYC Department of Health and Mental Hygiene Assia Bourib Satoshi Ezoe Michael Kessler Stephanie Nolen Matthew D'Uva Johanne Morne Emily Baumgaertner Guilherme Gon?alves Duarte, M.D. Kelly Henning, MD Rhitu Chatterjee Nur Bedeir Alina M. Allen Meena Bansal Jeffrey Mechanick Shikha Bharaktiya Jongoh Kim

A 2022 American Heart Association scientific statement recognized #MASLD as an often overlooked independent risk factor for atherosclerotic cardiovascular disease (CVD) and stated that increased risk of CVD in people living with MASLD is sometimes the result of its association with type 2 #diabetes and abdominal adiposity (source ?? https://lnkd.in/dMdw2XpU) What opportunities* are we missing ?? when it comes to MASLD/MASH and common risk factors in non-communicable diseases? -- *Taken from the 2024 policy brief by Economist Impact that provides an overview of the current US policy landscape for MASLD and MASH, alongside recommendations for policy-makers (https://lnkd.in/egPBWmKt) #MASHCities